Manzara Therapeutics, Inc. reported raising $750,000 in an initial SEC Form D filing, from an offering of $1.5 Million
Amount Raised
$750,000
Round Type
Seed
New YorkHealthcareWho else raised in Healthcare around the same time
Companies in the same sectors as Manzara Therapeutics, Inc. that raised within 45 days of this round, from Fundz verified event records.
- Ralexar Therapeutics, Inc. raised $1.9M (Seed) on January 4, 2019.
- REPLICATE Dental Technologies PLC raised an undisclosed amount on January 4, 2019.
- Metronom Health, Inc. raised $7M on January 4, 2019.
- Emerging Therapy Solutions, Inc. raised $5.3M on January 4, 2019.
- Cardio Flow, Inc. raised an undisclosed amount on January 4, 2019.
- Pear Therapeutics, Inc. raised $64M on January 4, 2019.
Who to call at Manzara Therapeutics, Inc., and when
A new round usually means Manzara Therapeutics, Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Manzara Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Manzara Therapeutics, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Manzara Therapeutics, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Manzara Therapeutics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Manzara Therapeutics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.